glioblastoma

Paradigm will use its NGS-based PCDx panel to characterize patient tissue samples in a phase I clinical study of altiratinib.

The CDx test will be developed to identify best responders for Apogenix's APG101 for treating solid tumors and malignant hematological diseases.

The funds will support work to evaluate the effectiveness of the company's immunosignature technology in the diagnosis of brain cancer.

NEW YORK (GenomeWeb) – A team led by researchers from the Human Proteome Organization's Chromosome-Centric Human Proteome Project has completed a study using data from the National Human Genome Research Institute's Encyclopedia of DNA Elements Consortium (ENCODE) to aid in identification of previ

NEW YORK (GenomeWeb) – A study published online today in Science Translational Medicine suggests the brain cancer glioblastoma multiforme (GBM) can shed cells that make their way into a patient's blood stream, arguing against the notion that the disease is mainly restricted to the centra

NEW YORK (GenomeWeb) – Israeli RNAi drug developer Silenseed has filed to go public in the US, looking to raise around $36.4 million to support the continued clinical development of its oncology pipeline and the implantable delivery system that enables it.

NEW YORK (GenomeWeb) — Cells that make up brain tumors are more heterogeneous than previously thought, according to a new single-cell transcriptomic analysis appearing in Science today.

In launching a new project to identify precision medicine approaches for glioblastoma patients, researchers at the New York Genome Center are anticipating "an absolute gusher" of information from the sequencing and RNA analysis they will perform on approximately 20 study particip

NEW YORK (GenomeWeb News) – Teva Pharmaceuticals will be the exclusive distributor of MDxHealth's tests for prostate cancer and glioblastoma in Israel under a deal announced today.

Researchers from George Mason University have completed an analysis of samples and data from the National Cancer Institute's Cancer Genome Atlas (TCGA) project that indicates that laser capture microdissection of tumor samples could improve proteomic analyses.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.